383 related articles for article (PubMed ID: 23232063)
1. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
2. Analysis of T and B Cell Epitopes to Predict the Risk of
Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
Front Immunol; 2020; 11():2000. PubMed ID: 32973806
[TBL] [Abstract][Full Text] [Related]
3. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
[TBL] [Abstract][Full Text] [Related]
4. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
5. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
[TBL] [Abstract][Full Text] [Related]
6. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
7. The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
Jucaud V
J Immunol Res; 2017; 2017():2748614. PubMed ID: 28331856
[TBL] [Abstract][Full Text] [Related]
8. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
9. Association between PIRCHE-II scores and de novo allosensitization after reduction of immunosuppression during SARS-CoV-2 infection in kidney transplant recipients.
Castrezana-Lopez K; Malchow R; Nilsson J; Kokkonen SM; Rho E; von Moos S; Mueller TF; Schachtner T
Transpl Infect Dis; 2023 Apr; 25(2):e14052. PubMed ID: 36884207
[TBL] [Abstract][Full Text] [Related]
10. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.
Ravindranath MH; Pham T; Ozawa M; Terasaki PI
Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577
[TBL] [Abstract][Full Text] [Related]
12. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
[TBL] [Abstract][Full Text] [Related]
13. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
14. PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.
Geneugelijk K; Niemann M; Drylewicz J; van Zuilen AD; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Hack CE; van Reekum FE; Verhaar MC; Kamburova EG; Bots ML; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy JNM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Spierings E
Front Immunol; 2018; 9():321. PubMed ID: 29556227
[TBL] [Abstract][Full Text] [Related]
15. Association of HLA B- and T-cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation.
Gramkow AM; Baatrup JH; Gramkow ET; Thiesson HC; Koefoed-Nielsen P
Pediatr Transplant; 2024 Aug; 28(5):e14773. PubMed ID: 38808702
[TBL] [Abstract][Full Text] [Related]
16. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate xenotransplantation provoke antibodies that cross-react with human leukocyte antigens?
Key T; Schuurman HJ; Taylor CJ
Xenotransplantation; 2004 Sep; 11(5):452-6. PubMed ID: 15303982
[TBL] [Abstract][Full Text] [Related]
17. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
[TBL] [Abstract][Full Text] [Related]
18. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
[TBL] [Abstract][Full Text] [Related]
19. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.
Thus KA; Ruizendaal MT; de Hoop TA; Borst E; van Deutekom HW; Te Boome L; Kuball J; Spierings E
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1705-10. PubMed ID: 24980111
[TBL] [Abstract][Full Text] [Related]
20. Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy.
Geneugelijk K; Hönger G; van Deutekom HW; Thus KA; Keşmir C; Hösli I; Schaub S; Spierings E
Am J Transplant; 2015 Dec; 15(12):3112-22. PubMed ID: 26512793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]